Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4170-3 ◽

2017 ◽

Vol 163 (1) ◽

pp. 51-61 ◽

Author(s):

Amila Orucevic ◽

John L. Bell ◽

Alison P. McNabb ◽

Robert E. Heidel

Keyword(s):

Breast Cancer ◽

Cancer Recurrence ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Recurrence

Download Full-text

BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score

BMC Clinical Pathology ◽

10.1186/s12907-018-0082-3 ◽

2018 ◽

Vol 18 (1) ◽

Author(s):

Mark D. Zarella ◽

Rebecca C. Heintzelman ◽

Nikolay K. Popnikolov ◽

Fernando U. Garcia

Keyword(s):

Breast Cancer ◽

Cancer Recurrence ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Recurrence

Download Full-text

Abstract P2-08-40: Reconsidering “at risk” criteria for breast cancer recurrence in hormone positive patients: Risk stratification is still important in patients with an Oncotype Dx recurrence score ≤ 25!

10.1158/1538-7445.sabcs18-p2-08-40 ◽

2019 ◽

Author(s):

BM Turner ◽

MAG Sanders ◽

A Soukiazian ◽

N Soukiazian ◽

DG Hicks

Keyword(s):

Breast Cancer ◽

At Risk ◽

Risk Stratification ◽

Cancer Recurrence ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Recurrence ◽

Risk Criteria ◽

Oncotype Dx Recurrence Score

Download Full-text

Abstract P5-11-01: The accuracy of nomograms based on large dataset using clinico-pathologic variables for prediction of oncotype DX breast cancer recurrence score

10.1158/1538-7445.sabcs17-p5-11-01 ◽

2018 ◽

Author(s):

J-M Kim ◽

JM Ryu ◽

I Kim ◽

HJ Choi ◽

SJ Nam ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Recurrence ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Recurrence ◽

Download Full-text

Abstract P2-08-09: Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data

10.1158/1538-7445.sabcs18-p2-08-09 ◽

2019 ◽

Author(s):

A Orucevic ◽

ML McNeil ◽

JL Bell ◽

AP McNabb ◽

RE Heidel

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Recurrence ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Recurrence ◽

Clinical Trial Results

Download Full-text

Abstract P3-07-06: ER+ patients with an average modified Magee score ≤ 18 have a low likelihood of breast cancer recurrence and a high likelihood of an Oncotype Dx® recurrence score < 26

10.1158/1538-7445.sabcs19-p3-07-06 ◽

2020 ◽

Author(s):

Hasan Khatib ◽

Mary Ann G Sanders ◽

Andrea Breaux ◽

Armen Soukiazian ◽

Nyrie Soukiazian ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Recurrence ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Recurrence ◽

High Likelihood

Download Full-text

Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data

10.1016/j.breast.2019.05.006 ◽

2019 ◽

Vol 46 ◽

pp. 116-125 ◽

Author(s):

Amila Orucevic ◽

John L. Bell ◽

Megan King ◽

Alison P. McNabb ◽

Robert E. Heidel

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Recurrence ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Recurrence ◽

Clinical Trial Results

Download Full-text

PCN42 Budget Impact Analysis of the Oncotype DX Breast Cancer Recurrence Score Test to Guide Chemotherapy Use in ER+/HER2- Node-Negative Early Invasive Breast Cancer

Value in Health ◽

10.1016/j.jval.2021.04.134 ◽

2021 ◽

Vol 24 ◽

pp. S26

Author(s):

V. Berdunov ◽

S. Millen ◽

A. Paramore ◽

S. Reynia ◽

N. Fryer ◽

...

Keyword(s):

Breast Cancer ◽

Invasive Breast Cancer ◽

Impact Analysis ◽

Budget Impact ◽

Cancer Recurrence ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Recurrence ◽

Download Full-text

Abstract PS5-18: Association of factors of the obesity phenotype with breast cancer recurrence risk measured by oncotype recurrence score and short-term response to neoadjuvant endocrine therapy

10.1158/1538-7445.sabcs20-ps5-18 ◽

2021 ◽

Author(s):

Riley Bergman ◽

Yvonne Berko ◽

Brent Rexer

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Cancer Recurrence ◽

Recurrence Score ◽

Recurrence Risk ◽

Breast Cancer Recurrence ◽

Neoadjuvant Endocrine Therapy ◽

Obesity Phenotype ◽

Download Full-text

P201 Meta-analysis of the decision impact of the 21-gene breast cancer Recurrence Score® in clinical practice

10.1016/s0960-9776(11)70142-4 ◽

2011 ◽

Vol 20 ◽

pp. S44 ◽

Author(s):

J.C. Hornberger ◽

R. Chien

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Meta Analysis ◽

Cancer Recurrence ◽

Recurrence Score ◽

Breast Cancer Recurrence

Download Full-text

Assessing the risk of breast cancer recurrence in node-positive patients with Oncotype DX and Adjuvant!

Community Oncology ◽

10.1016/s1548-5315(11)70497-1 ◽

2008 ◽

Vol 5 (9) ◽

pp. 485-487

Author(s):

Jame Abraham

Keyword(s):

Breast Cancer ◽

Cancer Recurrence ◽

Oncotype Dx ◽

Breast Cancer Recurrence ◽

Download Full-text